Serious drug-related adverse events were seen in three patients in the paclitaxel plus gemcitabine group ( interstitial pneumonia , anaphylaxis , and severe neutropenia ) and four in the cisplatin plus gemcitabine group ( pathological bone fracture , thrombocytopenia with subcutaneous haemorrhage , severe anaemia , and cardiogenic syncope ) .